- Home
- SNY vs APP Comparison
SNY vs APP Comparison
Compare SNY & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- APP
- Stock Information
- Founded
- SNY 1994
- APP 2012
- Country
- SNY France
- APP United States
- Employees
- SNY N/A
- APP N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- APP EDP Services
- Sector
- SNY Health Care
- APP Technology
- Exchange
- SNY Nasdaq
- APP Nasdaq
- Market Cap
- SNY 134.4B
- APP 127.6B
- IPO Year
- SNY N/A
- APP 2021
- Fundamental
- Price
- SNY $54.46
- APP $415.31
- Analyst Decision
- SNY Strong Buy
- APP Buy
- Analyst Count
- SNY 1
- APP 20
- Target Price
- SNY $60.00
- APP $398.05
- AVG Volume (30 Days)
- SNY 2.4M
- APP 6.1M
- Earning Date
- SNY 01-30-2025
- APP 02-12-2025
- Dividend Yield
- SNY 4.04%
- APP N/A
- EPS Growth
- SNY 2.94
- APP 363.16
- EPS
- SNY 4.60
- APP 4.53
- Revenue
- SNY $45,849,466,833.00
- APP $4,709,248,000.00
- Revenue This Year
- SNY $9.02
- APP $22.06
- Revenue Next Year
- SNY $6.31
- APP $21.45
- P/E Ratio
- SNY $23.70
- APP $91.59
- Revenue Growth
- SNY 7.73
- APP 43.44
- 52 Week Low
- SNY $45.22
- APP $57.09
- 52 Week High
- SNY $58.97
- APP $525.15
- Technical
- Relative Strength Index (RSI)
- SNY 62.24
- APP 53.47
- Support Level
- SNY $53.46
- APP $366.96
- Resistance Level
- SNY $55.04
- APP $519.79
- Average True Range (ATR)
- SNY 0.70
- APP 32.08
- MACD
- SNY -0.09
- APP 4.65
- Stochastic Oscillator
- SNY 75.32
- APP 37.57
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About APP Applovin Corporation
AppLovin Corp is a mobile app technology company. It focuses on growing the mobile app ecosystem by enabling the success of mobile app developers. The company's software solutions provide tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their applications.